Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...

This retrospective analysis included 102 patients with advanced RCC treated with either cabozantinib + nivolumab or lenvatinib + pembrolizumab as first-line therapy at Tokyo Women's Medical University ...